Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Income from Non-Controlling Interests: 2010-2025

Historic Income from Non-Controlling Interests for Arrowhead Pharmaceuticals (ARWR) over the last 9 years, with Sep 2025 value amounting to $31.7 million.

  • Arrowhead Pharmaceuticals' Income from Non-Controlling Interests rose 1519.91% to $39.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year increase of 411.23%. This contributed to the annual value of $31.7 million for FY2025, which is 411.23% up from last year.
  • Arrowhead Pharmaceuticals' Income from Non-Controlling Interests amounted to $31.7 million in FY2025, which was up 411.23% from -$10.2 million recorded in FY2024.
  • In the past 5 years, Arrowhead Pharmaceuticals' Income from Non-Controlling Interests registered a high of $31.7 million during FY2025, and its lowest value of -$10.2 million during FY2024.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Income from Non-Controlling Interests value was -$4.0 million (recorded in 2023), while the average stood at $5.8 million.
  • Per our database at Business Quant, Arrowhead Pharmaceuticals' Income from Non-Controlling Interests crashed by 828.07% in 2023 and then spiked by 411.23% in 2025.
  • Yearly analysis of 4 years shows Arrowhead Pharmaceuticals' Income from Non-Controlling Interests stood at -$431,000 in 2022, then crashed by 828.07% to -$4.0 million in 2023, then tumbled by 155.00% to -$10.2 million in 2024, then surged by 411.23% to $31.7 million in 2025.